Vasoactive intestinal peptide promotes hypophagia and metabolic changes: Role of paraventricular hypothalamic nucleus and nitric oxide

Brain Res Bull. 2022 Oct 15:189:102-110. doi: 10.1016/j.brainresbull.2022.08.021. Epub 2022 Aug 25.

Abstract

Vasoactive intestinal peptide (VIP), a neuromodulator present in the hypothalamus, plays an important role in the regulation of food intake. Paraventricular nucleus of the hypothalamus (PVN) is involved in ingestive responses and regulates the nitric oxide (NO) pathway. The main objectives of this study were to investigate metabolic changes established after different doses and times of VIP microinjection on the PVN, and the effect of VIP microinjection on the PVN on food intake and the role of NO in this control. In anesthetized rats, increased blood plasma glucose and insulin levels were observed following the doses of 40 and 80 ng/g of body weight. At the dose of 40 ng/g, VIP promoted hyperglycemia and hyperinsulinemia 5, 10, and 30 min after microinjection, and increased free fatty acids and total lipids plasma levels after 5 min, and triglycerides after 10 min. In awake animals, once again, VIP administration increased plasmatic levels of glucose, free fatty acids, corticosterone, and insulin 10 min after the microinjection. Moreover, VIP promoted hypophagia in the morning and night periods, and L-arginine (L-Arg) and monosodium glutamate (MSG) or a combination of both attenuated VIP-induced reduction on food intake. In addition, nitrate concentration in the PVN was decreased after VIP microinjection. Our data show that the PVN participates in the anorexigenic and metabolic effects of VIP, and that VIP-induced hypophagia is likely mediated by reduction of NO.

Keywords: Corticosterone; Free fatty acids; Glycemia; Insulin; L-arginine; Monosodium glutamate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / metabolism
  • Arginine / pharmacology
  • Blood Glucose / metabolism
  • Corticosterone
  • Fatty Acids, Nonesterified / metabolism
  • Fatty Acids, Nonesterified / pharmacology
  • Insulins* / metabolism
  • Insulins* / pharmacology
  • Neurotransmitter Agents / metabolism
  • Nitrates / metabolism
  • Nitric Oxide / metabolism
  • Paraventricular Hypothalamic Nucleus*
  • Rats
  • Sodium Glutamate / metabolism
  • Sodium Glutamate / pharmacology
  • Triglycerides / metabolism
  • Triglycerides / pharmacology
  • Vasoactive Intestinal Peptide / metabolism
  • Vasoactive Intestinal Peptide / pharmacology

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Insulins
  • Neurotransmitter Agents
  • Nitrates
  • Triglycerides
  • Nitric Oxide
  • Vasoactive Intestinal Peptide
  • Arginine
  • Sodium Glutamate
  • Corticosterone